60
Participants
Start Date
May 8, 2017
Primary Completion Date
April 30, 2026
Study Completion Date
February 29, 2040
CAR T Cells
"Three dose levels will be evaluated based on safety data from our current study of CD30 CAR T cells. Cohorts of three to six patients will be enrolled at each dose level. Each patient will receive one infusion of CAR modified T cells according to the following dosing schedule:~Dose Level One: 2x10\^7 cells/m2. Dose Level Two: 1x10\^8 cells/m2. Dose Level Three: 2x10\^8 cells/m2."
RECRUITING
Houston Methodist Hospital, Houston
RECRUITING
Texas Children's Hospital, Houston
The Methodist Hospital Research Institute
OTHER
Baylor College of Medicine
OTHER